CHESTGuidelines & Topic CollectionsInterstitial Lung Disease

Interstitial Lung Disease

Patient education assets


Promoting Diagnostic Excellence in ILD

Use the following resources to better understand recent guidelines addressing various ILDs.

LISTEN TO THE PODCAST »
Faculty: Julie Morisset, MD, and Ayodeji Adegunsoye, MD, MSc, PhD, FCCP
Moderator: Mary Beth Scholand, MD, FCCP
Eligible for 1 CME/CE/MOC
21 MINUTES


READ THE JOURNAL SERIES »
- The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work Group
- Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis
- Diagnosis and Management of Myositis-Associated Lung Disease
- Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification
Eligible for 4 CME/CE/MOC

This project is funded in part by the Gordon and Betty Moore Foundation through a grant program administered by the Council of Medical Specialty Societies.

Join the Diffuse Lung Disease and Lung Transplant Network

CHEST Networks are specialty-focused communities that provide forums for leadership, education, and advocacy. This Network enhances the scientific knowledge, evidence-based medicine, and clinical practices for health care providers in the areas of ILDs, lung transplant, occupational health, and pulmonary physiology and rehabilitation.

LEARN MORE »

ILD news and notes

Follow the latest ILD news

INTERSTITIAL LUNG DISEASE SECTION

Updates in evidence for rituximab in interstitial lung disease
Read about two clinical trials that investigated the use of rituximab in patients with severe or progressive autoimmune ILD and patients with systemic sclerosis-associated ILD.

QUALITY IMPROVEMENT PROJECTS

CHEST awards two grants for ILD research
Drs. Kavitha Selvan and Amirahwaty Abdullah received funding to implement quality improvement projects to shorten the time to diagnosis for patients with ILD.

PULMONOLOGY DATA TRENDS 2023

Progressive Pulmonary Fibrosis: Understanding Its Many Forms
Explore infographics on a new definition of PPF, its pathophysiology, and its associated financial burdens.

LUNG TRANSPLANT SECTION

CLAD prevention in lung transplant recipients: tacrolimus vs cyclosporin
A new study demonstrated that immunosuppressive regimens containing tacrolimus significantly reduced incidence of CLAD diagnosis at 36 months.

OCCUPATIONAL AND ENVIRONMENTAL HEALTH SECTION

Fighting for fresh air: RSV’s connection to environmental pollution
This article discusses the growing connection between air pollution and RSV prevalence, including the importance of vaccination for patients who are at risk.

PULMONARY PHYSIOLOGY AND REHABILITATION SECTION

Use of 6-minute walk distance as a clinical trial outcome in ILD
A decline in 6MWT results can represent progression of ILD; ILD-related PH; or musculoskeletal, hematologic, or cardiac etiologies related to the underlying cause of ILD.

Build your ILD expertise

CHEST SEEK™ Education

Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought process; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.


CHEST SEEK LIBRARY

Access hundreds of critical care, pulmonary, and sleep medicine questions.

PURCHASE NOW »

Join the community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »